Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy

Journal of Proteomics

Volumn 90, Issue , 2013, Pages 14-27

  Maerkens, A ^a,b   Kley, R A ^a   Olive M ^c   Theis, V ^a,b   van der Ven, P F M ^d   Reimann, J ^e   Milting, H ^f   Schreiner, A ^a   Uszkoreit, J ^b   Eisenacher, M ^b   Barkovits, K ^b   Guttsches A K ^a   Tonillo, J ^b   Kuhlmann, K ^b   Meyer, H E ^b   Schroder R ^g   Tegenthoff, M ^a   Furst D O ^d   Muller T ^b   Goldfarb, L G ^h   Vorgerd, M ^a   Marcus, K ^b   more..

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Desminopathy; Filaminopathy; Laser microdissection; Mass spectrometry; Myofibrillar myopathy; Parallel reaction monitoring

Indexed keywords

DESMIN; MUSCLE PROTEIN; PROTEOME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DESMINOPATHY; FEMALE; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOLOCALIZATION; LASER MICRODISSECTION; MASS SPECTROMETRY; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEOMICS; SKELETAL MUSCLE; CARDIOMYOPATHY; CLINICAL TRIAL; GENETIC DISORDER; GENETICS; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MUSCULAR DYSTROPHY; MUTATION; PATHOLOGY;

ADULT; AGED; CARDIOMYOPATHIES; FEMALE; GENETIC DISEASES, INBORN; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUTATION; PROTEOME; PROTEOMICS;

EID: 84882686603     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.04.026     Document Type: Article

References (51)

1. Olivé M., Odgerel Z., Martínez A., Poza J.J., Bragado F.G., Zabalza R.J., et al. Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 2011, 21:533-542.
2. Selcen D. Myofibrillar myopathies. Neuromuscul Disord 2011, 21:161-171.
3. Goldfarb L.G., Park K.Y., Cervenáková L., Gorokhova S., Lee H.S., Vasconcelos O., et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998, 19:402-403.
4. Clemen C.S., Herrmann H., Strelkov S.V., Schröder R. Desminopathies: pathology and mechanisms. Acta Neuropathol 2013, 125(1):47-75.
5. Herrmann H., Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu Rev Biochem 2004, 73:749-789.
6. Goldfarb L.G., Vicart P., Goebel H.H., Dalakas M.C. Desmin myopathy. Brain 2004, 127:723-734.
7. Maloyan A., Robbins J. Autophagy in desmin-related cardiomyopathy: thoughts at the halfway point. Autophagy 2010, 6.
8. Schröder R., Schoser B. Myofibrillar myopathies: a clinical and myopathological guide. Brain Pathol 2009, 19:483-492.
9. Klauke B., Kossmann S., Gaertner A., Brand K., Stork I., Brodehl A., et al. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet 2010, 19:4595-4607.
10. Claeys K.G., van der Ven P.F.M., Behin A., Stojkovic T., Eymard B., Dubourg O., et al. Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study. Acta Neuropathol 2009, 117:293-307.
11. Ferrer I., Olivé M. Molecular pathology of myofibrillar myopathies. Expert Rev Mol Med 2008, 10:e25.
12. Olivé M. Extralysosomal protein degradation in myofibrillar myopathies. Brain Pathol 2009, 19:507-515.
13. Selcen D., Ohno K., Engel A.G. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 2004, 127:439-451.
14. Lewis C., Carberry S., Ohlendieck K. Proteomic profiling of x-linked muscular dystrophy. J Muscle Res Cell Motil 2009, 30:267-269.
15. Thongboonkerd V., Kanlaya R., Sinchaikul S., Parichatikanond P., Chen S.T., Malasit P. Proteomic identification of altered proteins in skeletal muscle during chronic potassium depletion: implications for hypokalemic myopathy. J Proteome Res 2006, 5:3326-3335.
16. Li J., Yin C., Okamoto H., Jaffe H., Oldfield E.H., Zhuang Z., et al. Proteomic analysis of inclusion body myositis. J Neuropathol Exp Neurol 2006, 65:826-833.
17. Vorgerd M., van der Ven P.F.M., Bruchertseifer V., Löwe T., Kley R.A., Schröder R., et al. A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 2005, 77:297-304.
18. Fürst D.O., Goldfarb L.G., Kley R.A., Vorgerd M., Olivé M., van der Ven P.F.M. Filamin C-related myopathies: pathology and mechanisms. Acta Neuropathol 2013, 125(1):33-34.
19. Shatunov A., Olivé M., Odgerel Z., Stadelmann-Nessler C., Irlbacher K., van L.F., et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet 2009, 17:656-663.
20. Kley R.A., Maerkens A., Leber Y., Theiss V., Schreiner A., van der Ven P.F.M., et al. A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients. Mol Cell Proteomics 2012.
21. Olivé M., Armstrong J., Miralles F., Pou A., Fardeau M., Gonzalez L., et al. Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. Neuromuscul Disord 2007, 17:443-450.
22. Kley R.A., Hellenbroich Y., van der Ven P.F.M., Fürst D.O., Huebner A., Bruchertseifer V., et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 2007, 130:3250-3264.
23. Vrabie A., Goldfarb L.G., Shatunov A., Nägele A., Fritz P., Kaczmarek I., et al. The enlarging spectrum of desminopathies: new morphological findings, eastward geographic spread, novel exon 3 desmin mutation. Acta Neuropathol 2005, 109:411-417.
24. Goudeau B., Rodrigues-Lima F., Fischer D., Casteras-Simon M., Sambuughin N., de Visser M., et al. Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat 2006, 27:906-913.
25. Gallien S., Duriez E., Crone C., Kellmann M., Moehring T., Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 2012, 11(12):1709-1723.
26. Peterson A.C., Russell J.D., Bailey D.J., Westphall M.S., Coon J.J. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics 2012, 11(11):1475-1488.
27. Reidegeld K.A., Eisenacher M., Kohl M., Chamrad D., Korting G., Bluggel M., et al. An easy-to-use Decoy Database Builder software tool, implementing different decoy strategies for false discovery rate calculation in automated MS/MS protein identifications. Proteomics 2008, 8:1129-1137.
28. Spitzer P., Klafki H.W., Blennow K., Buee L., Esselmann H., Herruka S.K., et al. cNEUPRO: novel biomarkers for neurodegenerative diseases. Int J Alzheimers Dis 2010, 2010.
29. Müller T., Loosse C., Schrötter A., Schnabel A., Helling S., Egensperger R., et al. The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes. Curr Alzheimer Res 2011, 8:573-582.
30. Bennardini F., Wrzosek A., Chiesi M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ Res 1992, 71:288-294.
31. Steinert P.M., Chou Y.H., Prahlad V., Parry D.A., Marekov L.N., Wu K.C., et al. A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J Biol Chem 1999, 274:9881-9890.
32. van der Ven P.F.M., Ehler E., Vakeel P., Eulitz S., Schenk J.A., Milting H., et al. Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP. Exp Cell Res 2006, 312:2154-2167.
33. Schröder R., Vrabie A., Goebel H.H. Primary desminopathies. J Cell Mol Med 2007, 11:416-426.
34. Niederländer N., Fayein N.A., Auffray C., Pomiès P. Characterization of a new human isoform of the enigma homolog family specifically expressed in skeletal muscle. Biochem Biophys Res Commun 2004, 325:1304-1311.
35. Price M.G. Skelemins: cytoskeletal proteins located at the periphery of M-discs in mammalian striated muscle. J Cell Biol 1987, 104:1325-1336.
36. Kley R.A., Serdaroglu-Oflazer P., Leber Y., Odgerel Z., van der Ven P.F.M., Olivé M., et al. Pathophysiology of protein aggregation and extended phenotyping in filaminopathy. Brain 2012, 135:2642-2660.
37. Ferrer I., Martín B., Castaño J.G., Lucas J.J., Moreno D., Olivé M. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 2004, 63:484-498.
38. Olivé M., van Leeuwen F.W., Janué A., Moreno D., Torrejón-Escribano B., Ferrer I. Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies. Neuropathol Appl Neurobiol 2008, 34:76-87.
39. Geeraert C., Ratier A., Pfisterer S.G., Perdiz D., Cantaloube I., Rouault A., et al. Starvation-induced hyperacetylation of tubulin is required for the stimulation of autophagy by nutrient deprivation. J Biol Chem 2010, 285:24184-24194.
40. Hack L. On how to retain experienced RNs. Can Nurse 1998, 94:9-10.
41. Nishida K., Yamaguchi O., Otsu K. Crosstalk between autophagy and apoptosis in heart disease. Circ Res 2008, 103:343-351.
42. Platini F., Pérez-Tomás R., Ambrosio S., Tessitore L. Understanding autophagy in cell death control. Curr Pharm Des 2010, 16:101-113.
43. Selcen D., Engel A.G. Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol 2003, 54:804-810.
44. Selcen D., Muntoni F., Burton B.K., Pegoraro E., Sewry C., Bite A.V., et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 2009, 65:83-89.
45. Amato A.A., Jackson C.E., Lampkin S., Kagan-Hallet K. Myofibrillar myopathy: no evidence of apoptosis by TUNEL. Neurology 1999, 52:861-863.
46. Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 2000, 14:2989-3002.
47. Unkrüer B., Pekcec A., Fuest C., Wehmeyer A., Balda M.S., Horn A., et al. Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans. BMC Neurosci 2009, 10:28.
48. Kohno K., Izumi H., Uchiumi T., Ashizuka M., Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 2003, 25:691-698.
49. Saito Y., Nakagami H., Azuma N., Hirata S., Sanada F., Taniyama Y., et al. Critical roles of cold shock domain protein A as an endogenous angiogenesis inhibitor in skeletal muscle. Antioxid Redox Signal 2011, 15:2109-2120.
50. Bär H., Mücke N., Kostareva A., Sjöberg G., Aebi U., Herrmann H. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci U S A 2005, 102:15099-15104.
51. Feldkirchner S., Schessl J., Müller S., Schoser B., Hanisch F.-G. Patient-specific protein aggregates in myofibrillar myopathies: laser microdissection and differential proteomics for identification of plaque components. Proteomics 2012, 12(23-24):3598-3609.